Search results
Results from the WOW.Com Content Network
XBiotech was founded in 2005 in Vancouver, Canada by John Simard. [1] [3] The company moved its headquarters to Austin, Texas in 2008.[1]In September 2016, XBiotech was listed on Nasdaq, raising $70.9 million through its initial public offering (IPO).
Scientific American magazine has described BioCurious as "one of country’s premier community biotechnology labs [...]". [6] The lab debuted on Kickstarter in 2010 and raised $35,319 from backers, and opened in October 2011. [1] [7] [8] [9] BioCurious has supported projects including a 3D Bioprinter, glow-in-the-dark plants.
By 2023, Generate had raised financing, including a $273 million Series C round, the largest biotech Series C of the year. [2] These funds supported the company's first-in-human clinical trial for GB-0669, a monoclonal antibody targeting a conserved region of the SARS-CoV-2 spike protein , and its pipeline of 17 programs spanning immunology ...
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, [3] headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology.
Premier, Inc. is an American healthcare company, based in Charlotte, North Carolina. The company is listed on Nasdaq . In the early 2000s, Premier was a hospital buying group, pooling healthcare purchases to reduce prices.
For premium support please call: 800-290-4726 more ways to reach us
BioNTech was founded in 2008 based on research by Uğur Şahin, Özlem Türeci, [8] and Christoph Huber, [9] with a seed investment of €180 million [10] from MIG Capital, a Munich-based venture capital firm, the family office of Andreas and Thomas Strüngmann, and the present chairman of the supervisory board, Helmut Jeggle.
Precision BioSciences' proprietary technology is the ARCUS platform and ARCUS nucleases. [4] [8] ARCUS nucleases are based on a naturally occurring genome editing enzyme, I-CreI, a homing endonuclease that evolved in the algae Chlamydomonas reinhardtii [4] [12] to make highly specific cuts and DNA insertions in cellular DNA. [15]